8-Hydroxy-2’-Deoxyguanosine and Reactive Oxygen Species as Biomarkers of Oxidative Stress in Mental Illnesses: A Meta-Analysis

키워드

참고문헌 (96)

1. GBD 2017 Disease, "Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 392, pp.1789~1858 (2018)
2. Rehm J, "Global burden of disease and the impact of mental and addictive disorders", Curr Psychiatry Rep, 21, pp.10~ (2019)
3. Whiteford HA, "Mental, Neurological, and Substance Use Disorders: Disease Control Priorities", pp.2016, The International Bank for Reconstruction and Development
4. Halliwell B, "Oxidative stress and neurodegeneration: where are we now?", J Neurochem, 97, pp.1634~1658 (2006)
5. Ng F, "Oxidative stress in psychiatric disorders : Evidence base and therapeutic implications", Int J Neuropsychopharmacol, 11, pp.851~876 (2008)
6. Smaga I, "Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism", Pharmacol Rep, 67, pp.569~580 (2015)
7. Bulbul F, "Are oxidative stress markers useful to distinguish schizoaffective disorder from schizophrenia and bipolar disorder?", Acta Neuropsychiatr, 26, pp.120~124 (2014)
8. Zhang M, "A meta-analysis of oxidative stress markers in schizophrenia", Sci China Life Sci, 53, pp.112~124 (2010)
9. Katerji M, "Approaches and methods to measure oxidative stress in clinical samples : research applications in the cancer field", Oxid Med Cell Longev, 2019, pp.1279250~ (2019)
10. Hickerson RP, "Sequence and stacking dependence of 8-oxoguanine oxidation : comparison of oneelectron vs singlet oxygen mechanisms", J Am Chem Soc, 121, pp.9423~9428 (1999)
11. Raza MU, "DNA damage in major psychiatric diseases", Neurotox Res, 30, pp.251~267 (2016)
12. Valavanidis A, "8-Hydroxy-2’-deoxyguanosine(8-OHdG) : a critical biomarker of oxidative stress and carcinogenesis", J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 27, pp.120~139 (2009)
13. Ock CY, "8-hydroxydeoxyguanosine : Not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases", World J Gastroenterol, 18, pp.302~308 (2012)
14. Korkmaz KS, "Detection of 8-OHdG as a diagnostic biomarker", J Lab Precis Med, 3, pp.95~ (2018)
15. Salim S, "Oxidative stress and psychological disorders", Curr Neuropharmacol, 12, pp.140~147 (2014)
16. Brown NC, "An updated meta-analysis of oxidative stress markers in bipolar disorder", Psychiatry Res, 218, pp.61~68 (2014)
17. Liu T, "A meta-analysis of oxidative stress markers in depression", PLoS One, 10, pp.e0138904~ (2015)
18. Christensen MR, "Elevated levels of 8-oxoGuo and 8-oxodG in individuals with severe mental illness-An autopsy-based study", Free Radic Biol Med, 126, pp.372~378 (2018)
19. Huedo-Medina TB, "Assessing heterogeneity in meta-analysis: Q statistic or I2Index?", Psychol Methods, 11, pp.193~206 (2006)
20. Lin E, "Fixed-effects model: the most convincing model for meta-analysis with few studies", Preprint arXiv:2002.04211, ~
21. Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
22. Duval S, "Trim and fill : A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis", Biometrics, 56, pp.455~463 (2000)
23. Chestkov IV, "ROS-induced DNA damage associates with abundance of mitochondrial DNA in white blood cells of the untreated schizophrenic patients", Oxid Med Cell Longev, 2018, pp.8587475~ (2018)
24. Ershova ES, "Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patients", J Psychiatr Res, 87, pp.15~22 (2017)
25. Shmarina GV, "NRF2 and HMOX1 gene expression against the background of systemic oxidative stress in patients with acute psychosis", Russ J Genet, 56, pp.96~102 (2020)
26. Jorgensen A, "Increased systemic oxidatively generated DNA and RNA damage in schizophrenia", Psychiatry Res, 209, pp.417~423 (2013)
27. Nordholm D, "Systemic oxidative DNA and RNA damage are not increased during early phases of psychosis : a case control study", Psychiatry Res, 241, pp.201~ (2016)
28. Ibrahim RR, "Micro RNA 146a gene variant", TNF-α, IL-1 β; a cross-link axis in between oxidative stress, endothelial dysfunction and neuro-inflammation in acute ischemic stroke and chronic schizophrenic patients, pp.Arch Biochem, 2020[DOI]
29. Ma J, "A pilot study of biomarkers of oxidative stress in serum and schizophrenia", Psychiatry Res, 284, pp.112757~ (2020)
30. Copoglu US, "Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients", Psychiatry Res, 229, pp.200~205 (2015)
31. Şimşek Ş, "Oxidative stress and DNA damage in untreated first-episode psychosis in adolescents", Neuropsychobiology, 73, pp.92~97 (2016)
32. Miyaoka T, "Analysis of oxidative stress expressed by urinary level of biopyrrins and 8-hydroxydeoxyguanosine in patients with chronic schizophrenia", Psychiatry Clin Neurosci, 69, pp.693~698 (2015)
33. Jacoby AS, "Increased DNA and RNA damage by oxidation in patients with bipolar I disorder", Transl Psychiatry, 6, pp.e867~ (2016)
34. Munkholm K, "Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder", Bipolar Disord, 17, pp.257~268 (2015)
35. Knorr U, "Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls : a longitudinal case-control study", Transl Psychiatry, 9, pp.325~ (2019)
36. Soeiro-de-Souza MG, "Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder", Int J Neuropsychopharmacol, 16, pp.1505~1512 (2013)
37. Tsai MC, "Thiobarbituric acid reactive substances(TBARS)is a state biomarker of oxidative stress in bipolar patients in a manic phase", J Affect Disord, 173, pp.22~26 (2015)
38. Huzayyin AA, "Decreased global methylation in patients with bipolar disorder who respond to lithium", Int J Neuropsychopharmacol, 17, pp.561~569 (2014)
39. Ceylan D, "Alterations in levels of 8-Oxo-2’-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depression", Psychoneuroendocrinology, 114, pp.104600~ (2020)
40. Yi S, "Depressive symptoms and oxidative DNA damage in Japanese municipal employees", Psychiatry Res, 200, pp.318~322 (2012)
41. Black CN, "Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort", Psychol Med, 47, pp.936~948 (2017)
42. van Velzen LS, "Oxidative stress and brain morphology in individuals with depression, anxiety and healthy controls", Prog Neuropsychopharmacol Biol Psychiatry, 76, pp.140~144 (2017)
43. Lindqvist D, "Oxidative stress, inflammation and treatment response in major depression", Psychoneuroendocrinology, 76, pp.197~205 (2017)
44. Forlenza MJ, "Increased serum levels of 8-hydroxy-2’-deoxyguanosine in clinical depression", Psychosom Med, 68, pp.1~7 (2006)
45. Tsai MC, "Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder", Psychiatry Res, 235, pp.38~42 (2016)
46. Wei Y, "The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma", J Psychosom Res, 66, pp.259~266 (2009)
47. Wei YC, "Oxidative stress in depressive patients with gastric adenocarcinoma", Int J Neuropsychopharmacol, 12, pp.1089~1096 (2009)
48. Liu Z, "Leucocyte telomere shortening in relation to newly diagnosed type 2 diabetic patients with depression", Oxid Med Cell Longev, 2014, pp.673959~ (2014)
49. Dietrich-Muszalska A, "Oxidative stress in blood platelets from schizophrenic patients", Platelets, 16, pp.386~391 (2005)
50. Dietrich-Muszalska A, "Modifications of blood platelet proteins of patients with schizophrenia", Platelets, 20, pp.90~96 (2009)
51. Melamed Y, "Superoxide anion production by neutrophils derived from peripheral blood of schizophrenic patients", Psychiatry Res, 77, pp.29~34 (1998)
52. Sirota P, "Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients : parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity", Psychiatry Res, 121, pp.123~132 (2003)
53. Szuster-Ciesielska A, "Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.686~694 (2008)
54. Alcocer-Gómez E, "NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder", Brain Behav Immun, 36, pp.111~117 (2014)
55. Atanackovic D, "Immune parameters in patients with anxiety or depression during psychotherapy", J Affect Disord, 81, pp.201~209 (2004)
56. Chang CC, "Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder", Psychiatry Res, 230, pp.575~580 (2015)
57. Rybka J, "Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression", Free Radic Biol Med, 63, pp.187~194 (2013)
58. Andreazza AC, "Oxidative stress markers in bipolar disorder : a metaanalysis", J Affect Disord, 111, pp.135~144 (2008)
59. Flatow J, "Meta-analysis of oxidative stress in schizophrenia", Biol Psychiatry, 74, pp.400~409 (2013)
60. Rowland T, "Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder : systematic review and meta-analyses", Br J Psychiatry, 213, pp.514~525 (2018)
61. Markkanen E, "DNA damage and repair in schizophrenia and autism : implications for cancer comorbidity and beyond", Int J Mol Sci, 17, pp.856~ (2016)
62. Muraleedharan A, "Assessment of DNA damage and repair efficiency in drug naïve schizophrenia using comet assay", J Psychiatr Res, 68, pp.47~53 (2015)
63. Nishioka N, "Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia", Am J Geriatr Psychiatry, 12, pp.167~175 (2004)
64. Anderson IM, "Bipolar disorder", BMJ, 345, pp.e8508~ (2012)
65. Andreazza AC, "DNA damage in bipolar disorder", Psychiatry Res, 153, pp.27~32 (2007)
66. Frey BN, "Increased oxidative stress and DNA damage in bipolar disorder : a twin-case report", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.283~285 (2007)
67. Buttner N, "DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia", Schizophr Res, 93, pp.33~41 (2007)
68. Mustak MS, "Evidence of altered DNA integrity in the brain regions of suicidal victims of bipolar depression", Indian J Psychol Med, 52, pp.220~228 (2010)
69. Andreazza AC, "Serum S100B and antioxidant enzymes in bipolar patients", J Psychiatr Res, 41, pp.523~529 (2007)
70. Kessler RC, "The effects of stressful life events on depression", Annu Rev Psychol, 48, pp.191~214 (1997)
71. Patki G, "Depression, anxietylike behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress", Brain Res, 1539, pp.73~86 (2013)
72. Jiménez-Fernández S, "Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment", J Clin Psychiatry, 76, pp.1658~1667 (2015)
73. Palta P, "Depression and oxidative stress : Results from a meta-analysis of observational studies", Psychosom Med, 76, pp.12~19 (2014)
74. Black CN, "Is depression associated with increased oxidative stress? A systematic review and meta-analysis", Psychoneuroendocrinology, 51, pp.164~175 (2015)
75. Fletcher J, "What is heterogeneity and is it important?", Br Med J, 334, pp.94~96 (2007)
76. Thornton A, "Publication bias in meta-analysis : its causes and consequences", J Clin Epidemiol, 53, pp.207~216 (2000)
77. Mlinarić A, "Dealing with the positive publication bias: why you should really publish your negative results", Biochem Med, 27, pp.447~452 (2017)
78. Henriksen T, "Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2’-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry", Free Radic Biol Med, 47, pp.629~635 (2009)
79. Poulsen HE, "Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid", Biochim Biophys Acta, 1840, pp.801~808 (2014)
80. Collins AR, "The comet assay : topical issues", Mutagenesis, 23, pp.143~151 (2008)
81. Halliwell B, "Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come?", Am J Clin Nutr, 72, pp.1082~1087 (2000)
82. Kapczinski F, "Allostatic load in bipolar disorder : implications for pathophysiology and treatment", Neurosci Biobehav Rev, 32, pp.675~692 (2008)
83. Kapczinski F, "The potential use of biomarkers as an adjunctive tool for staging bipolar disorder", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.1366~1371 (2009)
84. Nguyen TT, "Systemic biomarkers of accelerated aging in schizophrenia : a critical review and future directions", Schizophr Bull, 44, pp.398~408 (2018)
85. Abdel-Wahab BA, "Does clozapine induce myocarditis, myocardial oxidative stress and DNA damage in rats?", Egypt J Forensic Sci, 4, pp.75~82 (2014)
86. Lin CH, "Early identification and intervention of schizophrenia : insight from hypotheses of glutamate dysfunction and oxidative stress", Front Psychiatry, 10, pp.93~ (2019)
87. Williams RE, "Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat", Toxicology, 207, pp.35~48 (2005)
88. Lin CH, "Sodium benzoate, a D-amino acid oxidase inhibitor, added to clozapine for the treatment of schizophrenia : a randomized, double-blind, placebo-controlled trial", Biol Psychiatry, 84, pp.422~432 (2018)
89. Shishikura M, "Evaluation of human D-amino acid oxidase inhibition by anti-psychotic drugs in vitro", Biosci Trends, 8, pp.149~154 (2014)
90. Martins MR, "Antipsychotic-induced oxidative stress in rat brain", Neurotox Res, 13, pp.63~69 (2008)
91. Freese E, "DNA damage caused by antidepressant hydrazines and related drugs", Mutat Res, 5, pp.343~348 (1968)
92. Alosaimi FD, "Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia", Neuropsychiatr Dis Treat, 12, pp.897~907 (2016)
93. Smith JA, "Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration", Neurochem Int, 62, pp.764~775 (2013)
94. Post A, "Differential induction of NF-κB activity and neural cell death by antidepressants in vitro", Eur J Neurosci, 12, pp.4331~4337 (2000)
95. Hamilton ML, "Does oxidative damage to DNA increase with age?", Proc Natl Acad Sci USA, 98, pp.10469~10474 (2001)
96. Graille M, "Urinary 8-OHdG as a biomarker for oxidative stress : a systematic literature review and meta-analysis", Int J Mol Sci, 21, pp.3743~ (2020)

관련 논문AI추천